Laddar...
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results
BACKGROUND: Multiple sclerosis (MS) is a chronic disease that may require decades of ongoing treatment. Therefore, the long-term safety and efficacy of disease-modifying therapies is an important consideration. METHODS: The LONGTERMS study evaluated the safety and efficacy of fingolimod in patients...
Sparad:
| I publikationen: | Ther Adv Neurol Disord |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763939/ https://ncbi.nlm.nih.gov/pubmed/31598139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419878324 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|